Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2521 – 2540 of 3236

Appendix B. Important Guideline Considerations

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-important-considerations

Isosporiasis (Cystoisosporiasis)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/isosporiasis

Emtricitabine (Emtriva, FTC)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-emtricitabine-emtriva

Entry and Attachment Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/entry-and-attachment-inhibitors

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/dolutegravir

Virologic Failure

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/virologic-failure

Lopinavir/Ritonavir

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/lopinavirritonavir

Doravirine (Pifeltro, DOR)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-doravirine-pifeltro

Adverse Effects of Antiretroviral Medications

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adverse-effects-antiretroviral-medications

Nephrotoxic Effects

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/nephrotoxic-effects

Enfuvirtide (Fuzeon, T-20)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-enfuvritide-fuzeon

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/stavudine

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/malaria

Candida Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/candida-infections

Candidiasis (Mucocutaneous)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/candidiasis

Varicella-Zoster Virus Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/varicella-zoster

https://clinicalinfo.hiv.gov/guidelines/perinatal/panel-roster

Postpartum HIV Management and Follow-Up

https://clinicalinfo.hiv.gov/guidelines/perinatal/postpartum-management-follow-up

Community-Acquired Bacterial Pneumonia

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/community-acquired

Laboratory Testing: Co-Receptor Tropism Assays

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/co-receptor-tropism-assays